• 247 Citations
  • 9 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Samira K Syed is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Matrix Metalloproteinase Inhibitors Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Sickle Cell Anemia Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 247 Citations
  • 9 h-Index
  • 18 Article
  • 1 Letter

Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer: Potential Biomarkers for Detection?

Stern, J. H., Arriaga, Y. E., Gupta, A., Verma, U., Karri, S., Syed, S. K., Khosama, L., Mansour, J., Meyer, J., Scherer, P. E. & Beg, M. S., Jan 1 2019, In : Pancreas. 48, 1, p. E1-E3

Research output: Contribution to journalLetter

Tumor Biomarkers
Pancreatic Neoplasms

Primary neuroendocrine carcinoma of the breast

Bergstrom, C., Porembka, J. H., Fang, Y. V., Sarode, V. R. & Syed, S. K., May 1 2019, In : Breast Journal. 25, 3, p. 519-520 2 p.

Research output: Contribution to journalArticle

Neuroendocrine Carcinoma
Clinical Trials
12 Citations (Scopus)

Phase I, pharmacokinetic and biological correlative study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor, and cisplatin in patients with solid tumors

Ricart, A. D., Berlin, J. D., Papadopoulos, K. P., Syed, S., Drolet, D. W., Quaratino-Baker, C., Horan, J., Chick, J., Vermeulen, W., Tolcher, A. W., Rowinsky, E. K. & Rothenberg, M. L., Dec 1 2008, In : Clinical Cancer Research. 14, 23, p. 7947-7955 9 p.

Research output: Contribution to journalArticle

Thymidylate Synthase
49 Citations (Scopus)

A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas

Chu, Q. S. C., Forouzesh, B., Syed, S., Mita, M., Schwartz, G., Copper, J., Curtright, J. & Rowinsky, E. K., Aug 2007, In : Investigational New Drugs. 25, 4, p. 359-367 9 p.

Research output: Contribution to journalArticle

Matrix Metalloproteinase Inhibitors
Matrix Metalloproteinases
Disease Progression